Last Updated: August 15, 2026

CLINICAL TRIALS PROFILE FOR EMFLAZA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for EMFLAZA

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03642145 ↗	A Study of Deflazacort (Emflaza®) in Participants With Duchenne Muscular Dystrophy (DMD)	Withdrawn	PTC Therapeutics	Phase 3	2018-10-31	The primary objective of this study is to evaluate the safety of a 0.9 milligrams per kilogram (mg/kg) and 0.45 mg/kg daily dose of deflazacort with a comparable natural history control group after 52 weeks of treatment in males with DMD aged greater than or equal to (>=) 2 to lesser than (
NCT03783923 ↗	A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)	Completed	PTC Therapeutics	Phase 3	2019-05-15	This study is designed to evaluate the safety and efficacy of deflazacort in participants with LGMD2I. Most participants enrolled will have a screening visit and 3 additional visits (after 1, 13, and 26 weeks of treatment).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for EMFLAZA

Condition Name

Chart
Table

Condition Name for EMFLAZA
Intervention	Trials
Duchenne Muscular Dystrophy	1
Limb-Girdle Muscular Dystrophy	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for EMFLAZA
Intervention	Trials
Muscular Dystrophies	2
Muscular Dystrophy, Duchenne	1
Muscular Dystrophies, Limb-Girdle	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for EMFLAZA

Trials by Country

Map
Table

Trials by Country for EMFLAZA
Location	Trials
United States	9
Canada	2
France	1
Russian Federation	1
Denmark	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for EMFLAZA
Location	Trials
Georgia	2
Missouri	1
Minnesota	1
Maryland	1
Kansas	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for EMFLAZA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for EMFLAZA
Clinical Trial Phase	Trials
Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for EMFLAZA
Clinical Trial Phase	Trials
Withdrawn	1
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for EMFLAZA

Sponsor Name

Chart
Table

Sponsor Name for EMFLAZA
Sponsor	Trials
PTC Therapeutics	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for EMFLAZA
Sponsor	Trials
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.